Depomed prices increased debt offering


Depomed (NASDAQ:DEPO) prices its $300M aggregate principal amount of convertible senior notes due 2021. The offering has been upsized from the original $230M amount. Buyers will have a 30-day option to purchase an additional $45M aggregate principal amount of the notes.

The notes will bear an interest rate of 2.50% per year payable semi-annually on March 1 and September 1. The conversion rate is 51.9852 shares of common stock per $1,000 principal amount which equates to ~$19.24 per share. Yesterday's close was $13.99.

Net proceeds of $290M - 334M will be used for working capital and general corporate purposes including potential acquisitions.

Closing date is September 9, 2014.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs